Good Pharmacovigilance Practice modules released by European Medicine Agency

March 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  …

Pharma’s international code of conduct extended

March 1, 2012
Medical Communications, Sales and Marketing Code of Practice, IFPMA, code of conduct

Pharma companies must adhere to a new stronger code of practice, no matter where they are in the world. The …

Lilly scientists

Academic alliances to speed Lilly’s R&D

March 1, 2012
Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

AstraZeneca announces several non-executive moves

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments

AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …

Rare Disease Day

‘Rare Disease Day’ highlights need for research

February 29, 2012
Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire

 Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …

A wake-up call for big pharma

February 29, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma

The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …

Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012
Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …

Shire image

Shire signs antibody research deal with arGEN-X

February 29, 2012
Research and Development Shire, arGEN-X, monoclonal antibodies

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …

LEO Pharma appoints new executive vice president

February 29, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain

From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …

NHS must adopt new technologies faster, says minister

February 28, 2012
Research and Development ABPI, NHS, Whitehead, Willetts, innovation

The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …

ICON acquires market access consultancy

February 28, 2012
Research and Development CRO, ICON, pharma market access, pricing and reimbursement

ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …

Sir David Nicholson

Doctors don’t want rationing responsibility, finds survey

February 28, 2012
Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing

 A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …

Jon Linscott to head PAN Advertising

February 28, 2012
Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising

Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies.   Linscott …

GSK picture

GSK recalls Novartis’ blood pressure drug

February 28, 2012
Manufacturing and Production DynaCirc CR, GSK, Novartis

GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …

EMA confirms verdict on Ben Venue facility

February 28, 2012
Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi

The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …

Shire image

Shire’s Vpriv plant wins EU approval

February 28, 2012
Manufacturing and Production EMA, Shire, Vpriv

Shire has been told by the European Medicines Agency that it can make use of a manufacturing facility in Lexington, …

Glivec

Glivec cleared for longer use in GIST patients

February 28, 2012
Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis

Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …

Lilly picture

Lilly plans €330m biomanufacturing plant in Ireland

February 28, 2012
Manufacturing and Production Abbott, Ireland, Kinsale, lilly

There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …

Endo says Opana ER supply disruption will be temporary

February 28, 2012
Manufacturing and Production Endo, Novartis, Opana ER

Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …

The Gateway to Local Adoption Series

Latest content